Achieve Life Sciences Inc.
NASDAQ:ACHV 3:59:52 PM EDT
| Market Cap (Intraday) | 64.00M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $6.74 |
| 50-Day MA | $7.24 |
| 200-Day MA | $7.63 |
Achieve Life Sciences Inc. Stock, NASDAQ:ACHV
1040 West Georgia Street, Suite 1030, Vancouver, British Columbia V6E 4H1
United States of America
Phone: +1.604.210.2217
Number of Employees: 16
Description
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.